Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Total Debt (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Total Debt for 4 consecutive years, with $539000.0 as the latest value for Q3 2025.

  • Quarterly Total Debt fell 74.88% to $539000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $539000.0 through Sep 2025, down 74.88% year-over-year, with the annual reading at $1.7 million for FY2024, 47.71% down from the prior year.
  • Total Debt for Q3 2025 was $539000.0 at Spruce Biosciences, down from $943000.0 in the prior quarter.
  • The five-year high for Total Debt was $4.9 million in Q4 2022, with the low at $539000.0 in Q3 2025.
  • Average Total Debt over 4 years is $3.2 million, with a median of $3.3 million recorded in 2023.
  • The sharpest move saw Total Debt decreased 7.51% in 2023, then crashed 74.88% in 2025.
  • Over 4 years, Total Debt stood at $4.9 million in 2022, then crashed by 32.07% to $3.3 million in 2023, then plummeted by 47.71% to $1.7 million in 2024, then tumbled by 69.13% to $539000.0 in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $539000.0, $943000.0, and $1.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.